As pets increasingly become integral members of our families, more pet owners are paying closer attention to their cats’ health. Among various feline health challenges, Feline Infectious Peritonitis (FIP) — once regarded as a “terminal illness” — is now being gradually overcome with innovative scientific treatments. As a pioneer in the field of pet healthcare, Miaite remains committed to its core principles of science, professionalism, and compassion, striving to provide safe, effective, and reliable solutions for comprehensive pet health management.

Professional Expertise, Deep Commitment to Pet Medicine

Miaite has long specialized in the research, development, and promotion of pet medications and health products, offering complete treatment and care solutions for common feline diseases. In the field of FIP treatment, Miaite’s flagship product, NeoFipronis® (Pronidesivir), has brought renewed hope and extended lives to thousands of cats worldwide.

Comprehensive Services, Scientifically Safeguarding Pet Health

Miaite not only provides innovative medicines but also offers holistic health support for pet owners:

• Disease Education: Professional resources to help owners understand FIP and other common feline diseases scientifically

• Medication Guidance: Accurate dosage recommendations, treatment plans, and tapering protocols

• Recovery Care: Nutritional and lifestyle guidance during both treatment and post-recovery stages

• Latest Updates: Timely insights into advancements in veterinary medicine and FIP research

Our Vision: Restoring Health, Enriching Lives

Miaite firmly believes that every pet’s life deserves to be protected. Beyond developing innovative therapies, Miaite focuses on education, empathy, and support, ensuring that pet owners and their companions are never alone in their journey. Looking ahead, Miaite will continue investing in cutting-edge research and driving advancements in veterinary medicine, with the ultimate goal of safeguarding the health and happiness of more cats across the globe.